Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151411 · ClinicalTrials.gov registry record · Phase 2
Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
NCT00151411 is a Phase 2 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 114 participants.
The verdict
NCT00151411, a Phase 2 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.
Interventions
- DRUG Placebo
- DRUG Metformin
- BEHAVIORAL Lifestyle Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00151411
The ClinicalTrials.gov registry entry for NCT00151411 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00151411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00151411 about?
NCT00151411 is a clinical study titled "Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)". The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.
What is the current status of trial NCT00151411?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2004-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00151411?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00151411?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.